UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say staff-driven ideas protect research independence in industry partnerships.
News|Articles|March 9, 2024
John Barbieri Talks Lab Monitoring Challenges and Alternative Approaches for Accutane in Acne Care | AAD 2024
Author(s)MHE Staff
Advertisement
John Barbieri, M.D., MBA, associate professor of Harvard Medical School, spoke with Managed Healthcare Executive at this year's American Academy of Dermatology Meeting in San Diego.
Barbieri discussed the significance of Accutane (isotretinoin) in managing severe or scarring acne and focused on the concerns surrounding lab monitoring, particularly liver enzyme and lipid testing.
Barbieri presented research at the meeting that suggests liver function testing may not provide meaningful insights, and lipid testing's value in preventing pancreatitis is questioned.
He highlighted the psychological, medical and financial costs associated with monitoring and discussed alternative approaches, suggesting limited monitoring based on baseline and peak dose labs.
Additionally, he mentioned the evolving standards, with some dermatologists still practicing monthly lab monitoring.
Advertisement
Related to this article
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say research justifies services and opens doors to limited distribution drugs.
Garza, an expert on hidradenitis suppurativa at Johns Hopkins, says increasing incidence of the disease on the Japanese island of Okinawa offer some "tantalizing clues" about reasons for the rising incidence.
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one NAD+ vial nationwide, citing a lack of assurance of sterility.
Pooja Roy, M.D., of Houston Methodist Hospital, discusses how Precedex (dexmedetomidine), an ICU sedative, sometimes triggers noninfectious fever, sparking costly sepsis workups, and the need for a test could help clinicians identify the drug as a cause of fever in ICUs.
Pope Leo early-stage adenocarcinoma is a reminder that lung nodules often cause no symptoms and that people who never smoked can get lung cancer.
Young-onset lung cancer often strikes nonsmokers, and current screening based on smoking is not likely to find it, says Singhi, an assistant professor at UT MD Anderson Cancer Center in Houston. New risk-based screening, liquid biopsies, and breath tests aim earlier detection.
Rex Hoffman, M.D., MBA, says physician shortages and burnout are the most underestimated pressures on health system.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Rex Hoffman, M.D., on physician burnout and collaborative leadership | HSES 2026
2
Rex Hoffman, M.D., on how a CMO balances competing priorities | HSES 2026
3
GLP-1 therapy tied to lower mortality and liver decompensation in older adults with MASLD
4
Algia Pharma completes investigational drug toxicology study for non-opioid acute pain regimen AlgiaPak
5